The effectiveness and tolerability of lercanidipine is independent of body mass index or body fat percent. The LERZAMIG study

  1. Barrios, V.
  2. Escobar, C.
  3. Calderón, A.
  4. Navarro, A.
  5. Ruilope, L.M.
Revue:
British Journal of Cardiology

ISSN: 0969-6113

Année de publication: 2006

Volumen: 13

Número: 6

Pages: 434-440

Type: Article

GOOGLE SCHOLAR
La source de données: Scopus